Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

Presentation Miami Valves 2024

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Presenter: Nicolas M. Van Mieghem

February 03, 2024

Presentation Miami Valves 2024

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Presenter: Nicolas M. Van Mieghem

February 03, 2024

Presentation Miami Valves 2024

Structural Heart Disease and Treatment

Presenter: Vivian Avila

February 03, 2024

Presentation Miami Valves 2024

Catheter Based Treatment of Structural Heart Disease: Year in Review

Presenter: Eduardo de Marchena

February 01, 2024

Presentation Miami Valves 2022

Catheter Based Treatment of Structural Heart Disease Year in Review 2022

Presenter: Eduardo de Marchena

February 03, 2022

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

Presentation

TAVR in Patients With End-Stage Renal Disease

June 11, 2019

Presentation Fellows 2019

Case Presentations: Complex Valvular Heart Disease

Presenter: Tamim Nazif

April 14, 2019

Presentation SIF 2019

Mixed Mitral and Aortic Valve Disease: Which One to Fix First?

Presenter: Brij Maini

March 30, 2019

Presentation JIM 2019

Complications in Trans-Catheter Valve and Structural Heart Disease Interventions

Presenter: Maurice Buchbinder

February 14, 2019

Presentation BIT 2019

Not All Left Main Disease is Atherosclerotic

Presenter: Gary S. Mintz

February 08, 2019

Presentation CIT 2018

Structural Heart Disease: What’s new in 2018?

Presenter: David Hildick-Smith

March 23, 2018

Presentation TCT 2017

30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

Presenter: Mayra Guerrero

November 01, 2017

Presentation ISCTR 2017

Valve Disease/Aortic Valve Replacement: Clinical Scientist Point of View

Presenter: Martin B. Leon

October 29, 2017

Presentation ISCTR 2017

Valve Disease/Transcatheter Aortic Valve Replacement: Regulatory Point of View

Presenter: Jaime Raben

October 29, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 2

Presenter: Mauricio G. Cohen

August 30, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 1

Presenter: George Hanzel

August 30, 2017

Presentation ESC 2017

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

Presentation TVT 2017

TAVR in Perspective Evolution, Impact, and Future Expectations

Presenter: Mark Reisman, Gregg W. Stone, Martin B. Leon

June 15, 2017

Advertisement

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Structural Heart Disease and Treatment

Catheter Based Treatment of Structural Heart Disease: Year in Review

Catheter Based Treatment of Structural Heart Disease Year in Review 2022

Show me the Data: Key Clinical Trials of 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

TAVR in Patients With End-Stage Renal Disease

Case Presentations: Complex Valvular Heart Disease

Mixed Mitral and Aortic Valve Disease: Which One to Fix First?

Complications in Trans-Catheter Valve and Structural Heart Disease Interventions

Not All Left Main Disease is Atherosclerotic

Structural Heart Disease: What’s new in 2018?

30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings

Valve Disease/Aortic Valve Replacement: Clinical Scientist Point of View

Valve Disease/Transcatheter Aortic Valve Replacement: Regulatory Point of View

Complications of Structural Heart Disease Intervention - Part 2

Complications of Structural Heart Disease Intervention - Part 1

Guidelines for the Management of Valvular Heart Disease

TAVR in Perspective Evolution, Impact, and Future Expectations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content